Rizatriptan Benzoate ODT
- Product NDC
- 72189-341
- Requested package NDC
- 72189-341-09
- 11-digit product format
- 721890341
- Labeler code
- 72189
- Product ID
- 72189-341_2c4c5f32-a754-7f96-e063-6394a90ad938
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rizatriptan Benzoate ODT
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA203062
- Marketing category
- ANDA
- Marketing start
- 2022-03-28
- Substance
- RIZATRIPTAN BENZOATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72189-341 | 72189-341-09 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72189-341 | 72189-341-09 | U | Excluded because listing certification expired | excluded / ndc_excluded.zip | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203062-001 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | |
| A203062-002 | RIZATRIPTAN BENZOATE | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203062-001 | AB |
| A203062-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-001 | RIZATRIPTAN BENZOATE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-002 | RIZATRIPTAN BENZOATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2013-07-01 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203062-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203062-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203062-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203062-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203062-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203062-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203062-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203062-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203062-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203062-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203062-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203062-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203062-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203062-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A203062-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203062-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A203062-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A203062-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A203062-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A203062-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A203062-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rizatriptan Benzoate ODT
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RIZATRIPTAN BENZOATE | 10 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WR978S7QHH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312837 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| db489d19-1509-c979-e053-2a95a90a4410 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f2791553-0b76-42f4-8d49-af3eda072bfb | Product name | 1 | 20251117 |
| 707ffe6e-db52-42b0-9a65-a0c00213f04f | Product name | 1 | 20231006 |
| 8b537454-32b8-7e64-1395-258682782d07 | Product name | 5 | 20170424 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-341-09 | Rizatriptan Benzoate ODT | 9 in 1 BOTTLE | TABLET, ORALLY DISINTEGRATING | 9 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-341-09 | EA - Each | 72189-341 | 5ebe3040-1ffd-4d33-b759-1ce69607e4e8 | 1 | 2022-04-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 11a7f243-3a8b-41fd-a9fa-1dd2dcafab93 | 2026-02-04 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Advanced Rx of Tennessee, LLC | 4137a02e-dcec-c14c-e063-6294a90aa44f | 2025-10-21 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Golden State Medical Supply, Inc. | 07605de4-bef2-70e8-e063-6394a90a33cc | 2025-08-20 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Aurobindo Pharma Limited | a8e37688-426c-4290-933d-54a34ae86000 | 2025-08-06 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | REMEDYREPACK INC. | 1e547fac-a9e5-4c7b-adba-4e6b75141183 | 2025-06-19 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Asclemed USA, Inc. | 8fa794f4-4253-485d-b4ee-986178031339 | 2025-01-27 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate ODT | RIZATRIPTAN BENZOATE ODT | Direct Rx | db489d19-1509-c979-e053-2a95a90a4410 | 2025-01-22 | Warnings, Adverse reactions | 203062 ANDA203062 72189-341-09 72189-341 72189034109 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Bryant Ranch Prepack | 74971372-75c6-4682-adbf-1c8e7b748fc1 | 2024-10-01 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Rising Pharma Holdings, Inc. | 2337e102-8df0-4e7f-81d8-5cb86cd48674 | 2024-02-19 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | NuCare Pharmaceuticals,Inc. | 106dd370-c09c-556a-e063-6394a90acfed | 2024-02-02 | Warnings, Adverse reactions | 203062 ANDA203062 |
| Rizatriptan Benzoate | RIZATRIPTAN BENZOATE | Proficient Rx LP | 80c124ab-a083-4184-ba6b-199a7681b5d1 | 2023-09-01 | Warnings, Adverse reactions | 203062 ANDA203062 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312837 | rizatriptan benzoate 10 MG Disintegrating Oral Tablet | PSN | db489d19-1509-c979-e053-2a95a90a4410 | 2 |
| 312837 | rizatriptan 10 MG Disintegrating Oral Tablet | SCD | db489d19-1509-c979-e053-2a95a90a4410 | 2 |
| 312837 | rizatriptan 10 MG (as rizatriptan benzoate 14.53 MG) Disintegrating Oral Tablet | SY | db489d19-1509-c979-e053-2a95a90a4410 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 72189-341-09 | 72189034109 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72189-341-09) | 2022-03-28 | 0000-00-00 | No | No | Current |